{"data":{"id":"us-tx/tex.-health-and-safety-code-1003.060","jurisdiction":"us-tx","citation":"Tex. Health and Safety Code § 1003.060","heading":"CONSTRUCTION OF SUBCHAPTER.","body":"This subchapter may not be construed to:\n(1) prohibit a physician from using adult stem cells for their intended homologous use if the stem cells are:\n(A) produced by a manufacturer registered by the United States Food and Drug Administration; and\n(B) commercially available; or\n(2) require an institutional review board to oversee treatment using adult stem cells registered by the United States Food and Drug Administration for their intended homologous use.\nAdded by Acts 2019, 86th Leg., R.S., Ch. 1158 (H.B. 3148), Sec. 5, eff. September 1, 2019.","path":["HEALTH AND SAFETY CODE","TITLE 12. HEALTH AND MENTAL HEALTH","CHAPTER 1003. ADULT STEM CELLS","SUBCHAPTER B. PROVISION OF INVESTIGATIONAL STEM CELL TREATMENTS TO PATIENTS WITH CERTAIN SEVERE CHRONIC DISEASES OR TERMINAL ILLNESSES"],"source_url":"https://statutes.capitol.texas.gov/Docs/HS/htm/HS.1003.htm#1003.060","current_through":"89th 2nd Called Legislative Session, 2025","vintage":"","retrieved_at":"2026-08-27T01:47:17Z","sha256":"ffc3c49a2f43ca7d6271b280d5b9224f08dd8dfbe6bdb78434765fe09afd0215","source_id":"us-tx","stale":false,"prev":"us-tx/tex.-health-and-safety-code-1003.059","next":"us-tx/tex.-health-and-safety-code-1101.001"},"notice":"GroundRules: Original legal text. Not legal advice."}